Repositioning antispasmodic drug Papaverine for the treatment of chronic myeloid leukemia.

Phani Krishna ParchaSailu SarvagallaCheemala AshokS J SudharshanMadhu DyavaiahMohane Selvaraj CoumarBaskaran Rajasekaran

Published in: Pharmacological reports : PR (2021)

The data presented here have added support to the concept of polypharmacology of existing drugs and natural compounds to interact with more than one target. This study provides a proof-of-concept for repositioning Papaverine as an anti-CML drug.

Keyphrases

chronic myeloid leukemia
drug induced
electronic health record
adverse drug
big data